Auransa to Participate in BioCentury-BayHelix China Healthcare Summit 2019
12. November 2019 08:05 ET
|
Auransa
PALO ALTO, Calif., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Auransa, Inc., an artificial intelligence (AI)-driven pharmaceutical company developing precision medicines in areas of significant unmet medical...
Auransa Presents New Preclinical Data on AU-409, a Novel, AI-Derived Drug Candidate for the Treatment of Hepatocellular Carcinoma
23. September 2019 08:05 ET
|
Auransa
PALO ALTO, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Auransa Inc., an artificial intelligence (AI)-driven biotechnology company developing precision medicines in areas of significant unmet medical...
Auransa Announces CEO to Participate on Executive Leadership Panel at the 6th Annual Indy Big Data Conference
12. September 2019 08:05 ET
|
Auransa
PALO ALTO, Calif., Sept. 12, 2019 (GLOBE NEWSWIRE) -- Auransa Inc., an artificial intelligence (AI)-driven biotechnology company developing precision medicines in areas of significant unmet medical...
Auransa to Participate in BioCentury's 26th Annual Future Leaders in the Biotech Industry Conference
08. April 2019 08:05 ET
|
Auransa
PALO ALTO, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- Auransa Inc., an artificial intelligence (AI)-driven biotechnology company developing precision medicines in areas of significant unmet medical...
Auransa to Present at Biotech Showcase 2019
02. Januar 2019 08:05 ET
|
Auransa
PALO ALTO, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Auransa Inc., an artificial intelligence (AI)-driven biotechnology company developing precision medicines in areas of significant unmet medical...
Auransa Enters into Exclusive Licensing Agreement with China Oncology Focus Limited, an Affiliate of Lee’s Pharmaceutical Holdings, for Rights to AU018 in Greater China and Southeast Asia
19. Dezember 2018 07:05 ET
|
Auransa
Auransa to Receive Upfront Payment and be Eligible for Milestone Payments and Sales Royalties for Preclinical Program Identified by Company’s AI-Driven SMarTR™ Engine China Oncology Focus to Receive...
Auransa to Participate in BioCentury-BayHelix China Healthcare Summit 2018
06. November 2018 08:05 ET
|
Auransa
PALO ALTO, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Auransa, Inc., an artificial intelligence (AI)-driven pharmaceutical company developing precision medicines in areas of significant unmet medical...